Get Started
HBV Curricula
Step 1




Chronic Hepatitis B:
The Advanced Curriculum
  1. Curriculum VII
  2. Curriculum VI
  3. Curriculum V
  4. Curriculum IV
  5. Full Course List
Co-Chairs
faculty image
Adrian M. Di Bisceglie, MD, FACP
  • Badeeh A. & Catherine V. Bander
  • Chair in Internal Medicine
  • Chairman and Professor of Internal Medicine
  • Chief of Hepatology
  • Saint Louis University
  • School of Medicine
  • St. Louis, Missouri
  • faculty image
    Robert G. Gish, MD
  • Medical Director
  • Center for Hepatobiliary Disease and Abdominal Transplantation
  • Chief of Hepatology
  • Professor of Medicine
  • University of California San Diego
  • San Diego, California
  • Adrian M. Di Bisceglie, MD, FACP, and Robert G. Gish, MD, co-chair this free, long-form CME/CE curriculum featuring new and engaging courses that offer the latest information and case discussions on topics such as screening, current and emerging treatment strategies, IL28, HCC, renal dysfunction, and hepatitis delta. Get clarity and guidance from prominent hepatology experts on key issues and practice challenges. Earn CME/CE credit and complete all courses to earn your Certificate of Advanced Study.
  • Analyze the disease burden posed by HBV and assess the importance of implementing early screening and diagnosis of patients for HBV infection.
  • Evaluate and address cultural/language barriers to optimal screening, diagnosis, and treatment of HBV in high-risk groups (eg, Asian-Pacific Islanders, Latinos, and others).
  • Evaluate the clinical relevance/thresholds for HBV tests to determine who and when to treat, optimal treatment selection, and on-treatment response to therapy.
  • Evaluate anti-HBV treatment guidelines to determine optimal screening, diagnosis, and treatment recommendations.
  • Formulate anti-HBV treatment strategies based on efficacy, safety, and resistance profiles of treatments, monitor and manage treatment response/resistance, and, if necessary, determine when to switch and when to add on treatments to optimize patient outcomes.
  • Implement optimal treatment selection for special populations (transplants, immune compromised, pregnant, etc).
  • Analyze how HBV leads to hepatocellular carcinoma and/or cirrhosis.
  • Target Audience

    This series of activities is designed for gastroenterologists, hepatologists, infectious disease specialists, internal medicine and primary care providers, nurse practitioners, nurses, physician assistants, and pharmacists who specialize in and care for patients with HBV.

     

    Activity Goal

    The goal of Chronic Hepatitis B: The Advanced Curriculum is to increase clinicians’ awareness of HBV disease prevalence, prevention strategies, and screening and diagnostic methodology within the high-risk HBV patient populations; bridge cultural differences in communicating diagnosis and treatment; provide current and emerging strategies for the selection of patients for treatment; educate clinicians on current treatment options; and expand on treatment management skills for HBV-infected patients.